PALB2 and breast carcinoma: These gene panels now typically include the so-called ‘moderate-risk’ breast cancer susceptibility genes, including PALB2, CHEK2 and ATM.1–3 However, mutations in these genes are individually extremely rare and limited data are available with which to accurately estimate the risk of cancer associated with them.